Company Can-Fite BioPharma Ltd. Nyse

Equities

CANF

US13471N1028

Pharmaceuticals

End-of-day quote Nyse 18:00:00 2024-02-04 EST 5-day change 1st Jan Change
2.02 USD -3.35% Intraday chart for Can-Fite BioPharma Ltd. -4.04% -8.18%

Business Summary

Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Sales per Business

ILS in Million2022Weight2023Weight Delta
Biopharmaceuticals
100.0 %
3 100.0 % 3 100.0 % +0.69%

Sales per region

ILS in Million2022Weight2023Weight Delta
Israel
100.0 %
3 100.0 % 3 100.0 % +0.69%

Managers

Managers TitleAgeSince
Chief Executive Officer 59 03-07-31
Founder 74 94-09-10
Founder 68 94-09-10
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Corporate Officer/Principal 52 03-12-31
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 76 00-12-31
Founder 68 94-09-10
Founder 74 94-09-10
Director/Board Member 68 17-07-31
Director/Board Member 55 11-06-30
Director/Board Member 66 21-08-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,497,128,493 1,496,706,120 ( 99.97 %) 0 99.97 %

Shareholders

NameEquities%Valuation
IBI Mutual Funds Management (1978) Ltd.
0.1477 %
2,210,774 0.1477 % 15 409 $
Alumot Sprint Mutual Funds Management Ltd.
0.0730 %
1,092,174 0.0730 % 7 612 $
263,433 0.0176 % 1 836 $
Ilan Cohn
0.008922 %
133,567 0.008922 % 931 $
Guy Regev
0.001619 %
24,240 0.001619 % 169 $
Ramco Mutual Funds Management (1989) Ltd.
0.001469 %
22,000 0.001469 % 153 $
Millennium Mutual Funds Ltd.
0.000142 %
2,120 0.000142 % 15 $
1,133 0.000076 % 8 $
0 0.000000 % - $
Sari Fishman
0.000000 %
0 0.000000 % - $
NameEquities%Valuation
Armistice Capital LLC
7.671 %
382,798 7.671 % 734 972 $
Morgan Stanley Capital Services LLC
1.118 %
55,807 1.118 % 107 149 $
RhumbLine Advisers LP
0.3703 %
18,482 0.3703 % 35 485 $
Citadel Securities GP LLC
0.2840 %
14,171 0.2840 % 27 208 $
3,000 0.0601 % 5 760 $
UBS Securities LLC
0.0435 %
2,172 0.0435 % 4 170 $
National Bank Financial, Inc.
0.0120 %
600 0.0120 % 1 152 $
Citigroup Global Markets, Inc. (Investment Management)
0.0111 %
553 0.0111 % 1 062 $

Company contact information

Can-Fite BioPharma Ltd.

26 Ben Gurion Street

5257346, Ramat Gan

+972 3 924 1114

http://www.canfite.com
address Can-Fite BioPharma Ltd.(CANF)
  1. Stock Market
  2. Equities
  3. CANF Stock
  4. CANF Stock
  5. Company Can-Fite BioPharma Ltd.